CAS 1260595-18-3
:Rasagiline N-β-D-Glucuronide SodiuM Salt, 90%
Description:
Rasagiline N-β-D-Glucuronide Sodium Salt is a chemical compound derived from rasagiline, a selective monoamine oxidase B inhibitor used primarily in the treatment of Parkinson's disease. This compound is characterized by its glucuronide conjugation, which enhances its solubility and bioavailability. The sodium salt form indicates that it is a sodium ion-associated compound, which can influence its stability and solubility in aqueous solutions. Typically, such glucuronide derivatives exhibit improved pharmacokinetic properties, including altered metabolism and excretion pathways. The compound is expected to be a white to off-white solid, and its purity is indicated to be 90%, suggesting a high degree of refinement suitable for research or pharmaceutical applications. As with many glucuronides, it may also exhibit specific interactions with enzymes involved in drug metabolism, particularly UDP-glucuronosyltransferases. Safety and handling precautions should be observed, as with any chemical substance, particularly in laboratory settings.
Formula:C18H21NO6
Synonyms:- (1R)-2,3-Dihydro-N-2-propyn-1-yl-1H-inden-1-aMine N-β-D-Glucuronide SodiuM Salt
- Rasagiline N-β-D-Glucuronide SodiuM Salt, 90%
- β-D-Glucopyranuronic acid, 1-deoxy-1-[[(1R)-2,3-dihydro-1H-inden-1-yl]-2-propyn-1-ylamino]-
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
